1Bennetw M , Demattos A , Meyerm M, et al . Chronic cyclosporine nephropathy:the Achilles heel of immunosuppressive therapy[J]. Kid Int ,1996 , 50 ( 4 ) : 1089-1100.
2Andoht F,Burdman A,Bnnett WM. Nephrotoxicity of immunosuppressive drugs : experimental and clinical observations [J]. Semin Nephrol ,1997,17 (1) :34-45.
3Morales JM, Campistol JM, Kreis H, et al. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transp lant patients[J] Transplant Proc , 2005, 37 (2) : 693-696.
4Dervaux T, Caillard S, Meyer C, et al . Is sirolimus responsible for proteinuria[J]. Transplant Proc , 2005, 37 (6) : 2828-2829.
5Martin KA, Rzucidlo EM, Merenick BL, et al . The roTOR / p70 S6K1 pathway regulates vascular smooth muscle cell differentia tion[J]. Am J Physiol Cell Physiol , 2004, 286 (3) : C507-517.
6Vazquez MA. Chronic rejection of renal transplants: new clinical insights[J]. Am J Med Sci , 2000, 320 (1) : 43-58.
7Diekmann F, Campistol JM. Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks[J]. Nephrol Dial Transplant ,2006, 21(3): 562-568.
8A. F. V. Franco, D. Martini, H. Abensur. Proteinuria in Transplant Patients Associated With Sirolimus [ J ]. Transplant Proc , 2007,39, 449-452.
9Ruiz JC, Diekmann F, Campistol JM, et al. Evolution of proteinuria alter conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study[J]. Transplant Proc ,2005, 37(9) :3833-3835.
10Fritz Diekmann , Klemens Budde. Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction[J]. Am J Transplant , 2004,4: 1869- 1875.
